Lantibiotic resistance

Microbiology and Molecular Biology Reviews

Volumn 79, Issue 2, 2015, Pages 171-191

  Draper, Lorraine A ^a,b   Cotter, Paul D ^b,c   Hill, Colin ^a,b   Ross, R Paul ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; LANTIBIOTIC; LIPID; LIPOPOLYSACCHARIDE; NISIN; PENICILLIN BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGMA FACTOR; ANTIINFECTIVE AGENT; BACTERIOCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL MEMBRANE; BACTERIAL SPORE; BIOFILM; CELL MEMBRANE; CELL WALL; HUMAN; LIPID COMPOSITION; LISTERIA MONOCYTOGENES; NONHUMAN; OPERON; PEPTOCLOSTRIDIUM DIFFICILE; STAPHYLOCOCCUS AUREUS; BACTERIUM; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; MOLECULAR MIMICRY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOCINS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; MOLECULAR MIMICRY; NISIN; PENICILLIN-BINDING PROTEINS;

EID: 84933497679     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00051-14     Document Type: Article

References (218)

1. Rea MC, Ross RP, Cotter PD, Hill C. 2011. Classification of bacteriocins from Gram-positive bacteria, p 29-53. In Drider D, Rebuffat S (ed), Prokaryotic antimicrobial peptides. Springer, New York, NY.
2. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, de Kruijff B, Sahl HG. 2001. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276:1772-1779. http://dx.doi.org/10.1074/jbc.M006770200.
3. Cotter PD, Hill C, Ross RP. 2005. Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sci 6:61-75. http://dx.doi.org/10.2174/1389203053027584.
4. Piper C, Cotter PD, Ross RP, Hill C. 2009. Discovery of medically significant lantibiotics. Curr Drug Discov Technol 6:1-18. http://dx.doi.org/10.2174/157016309787581075.
5. Cotter PD, Ross RP, Hill C. 2013. Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 11:95-105. http://dx.doi.org/10.1038/nrmicro2937.
6. Asaduzzaman SM, Nagao J, Aso Y, Nakayama J, Sonomoto K. 2006. Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1. Appl Environ Microbiol 72:6012-6017. http://dx.doi.org/10.1128/AEM.00678-06.
7. Moll GN, Roberts GC, Konings WN, Driessen AJ. 1996. Mechanism of lantibiotic-induced pore-formation. Antonie Van Leeuwenhoek 69: 185-191. http://dx.doi.org/10.1007/BF00399423.
8. Deegan LH, Suda S, Lawton EM, Draper LA, Hugenholtz F, Peschel A, Hill C, Cotter PD, Ross RP. 2010. Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147. Microb Biotechnol 3:222-234. http://dx.doi.org/10.1111/j.1751-7915.2009.00145.x.
9. Van Kraaij C, Breukink E, Rollema HS, Siezen RJ, Demel RA, Kruijff B, Kuipers OP. 1997. Influence of charge differences in the C-terminal part of nisin on antimicrobial activity and signaling capacity. Eur J Biochem 247: 114-120. http://dx.doi.org/10.1111/j.1432-1033.1997.00114.x.
10. Biswas S, Biswas I. 2014. A conserved streptococcal membrane protein, LsrS, exhibits a receptor-like function for lantibiotics. J Bacteriol 196: 1578-1587. http://dx.doi.org/10.1128/JB.00028-14.
11. Brotz H, Josten M, Wiedemann I, Schneider U, Gotz F, Bierbaum G, Sahl HG. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol 30:317-327. http://dx.doi.org/10.1046/j.1365-2958.1998.01065.x.
12. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl H, de Kruijff B. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286:2361-2364. http://dx.doi.org/10.1126/science.286.5448.2361.
13. Wiedemann I, Bottiger T, Bonelli RR, Wiese A, Hagge SO, Gutsmann T, Seydel U, Deegan L, Hill C, Ross P, Sahl HG. 2006. The mode of action of the lantibiotic lacticin 3147 - a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol 61:285-296. http://dx.doi.org/10.1111/j.1365-2958.2006.05223.x.
14. Wiedemann I, Bottiger T, Bonelli RR, Schneider T, Sahl HG, Martinez B. 2006. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl Environ Microbiol 72:2809-2814. http://dx.doi.org/10.1128/AEM.72.4.2809-2814.2006.
15. Brotz H, Bierbaum G, Leopold K, Reynolds PE, Sahl HG. 1998. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother 42:154-160.
16. Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, Kaptein R, Bonvin AM, van Nuland NA. 2004. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol 11:963-967. http://dx.doi.org/10.1038/nsmb830.
17. Bierbaum G, Sahl HG. 2009. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10:2-18. http://dx.doi.org/10.2174/138920109787048616.
18. Pag U, Heidrich C, Bierbaum G, Sahl HG. 1999. Molecular analysis of expression of the lantibiotic pep5 immunity phenotype. Appl Environ Microbiol 65:591-598.
19. Benz R, Jung G, Sahl HG. 1991. Mechanism of channel-formation by lantibiotics in black lipid membranes, p 359-372. In Jung G, Sahl HG (ed), Nisin and novel lantibiotics: proceedings of the First International Workshop on Lantibiotics. Escom, Leiden, The Netherlands.
20. Sahl HG. 1991. Pore formation in bacterial membranes by cationic lantibiotics, p 347-358. In Jung G, Sahl HG (ed), Nisin and novel lantibiotics: proceedings of the First International Workshop on Lantibiotics. Escom, Leiden, The Netherlands.
21. Driessen AJ, van den Hooven HW, Kuiper W, van de Kamp M, Sahl HG, Konings RN, Konings WN. 1995. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry 34:1606-1614. http://dx.doi.org/10.1021/bi00005a017.
22. Chikindas ML, Novak J, Driessen AJ, Konings WN, Schilling KM, Caufield PW. 1995. Mutacin II, a bactericidal antibiotic from Streptococcus mutans. Antimicrob Agents Chemother 39:2656-2660. http://dx.doi.org/10.1128/AAC.39.12.2656.
23. Brotz H, Bierbaum G, Markus A, Molitor E, Sahl HG. 1995. Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob Agents Chemother 39:714-719. http://dx.doi.org/10.1128/AAC.39.3.714.
24. Machaidze G, Seelig J. 2003. Specific binding of cinnamycin (Ro 09-0198) to phosphatidylethanolamine. Comparison between micellar and membrane environments. Biochemistry 42:12570-12576. http://dx.doi.org/10.1021/bi035225b.
25. Bonelli RR, Schneider T, Sahl HG, Wiedemann I. 2006. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob Agents Chemother 50:1449-1457. http://dx.doi.org/10.1128/AAC.50.4.1449-1457.2006.
26. Hurst A. 1981. Nisin. Adv Appl Microbiol 27:85-123. http://dx.doi.org/10.1016/S0065-2164(08)70342-3.
27. Paik SH, Chakicherla A, Hansen JN. 1998. Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168. J Biol Chem 273:23134-23142. http://dx.doi.org/10.1074/jbc.273.36.23134.
28. Gut IM, Prouty AM, Ballard JD, van der Donk WA, Blanke SR. 2008. Inhibition of Bacillus anthracis spore outgrowth by nisin. Antimicrob Agents Chemother 52:4281-4288. http://dx.doi.org/10.1128/AAC.00625-08.
29. Rink R, Wierenga J, Kuipers A, Kluskens LD, Driessen AJ, Kuipers OP, Moll GN. 2007. Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl Environ Microbiol 73:5809-5816. http://dx.doi.org/10.1128/AEM.01104-07.
30. Gut IM, Blanke SR, van der Donk WA. 2011. Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin. ACS Chem Biol 6:744-752. http://dx.doi.org/10.1021/cb1004178.
31. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian KD, Fischbach MA, Garavelli JS, Göransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJ, Rebuffat S, Ross RP, Sahl HG, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, Süssmuth RD, Tagg JR, Tang GL, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA. 2013. Ribosomally synthesized and posttranslationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30:108-160. http://dx.doi.org/10.1039/c2np20085f.
32. Kodani S, Lodato MA, Durrant MC, Picart F, Willey JM. 2005. SapT, a lanthionine-containing peptide involved in aerial hyphae formation in the streptomycetes. Mol Microbiol 58:1368-1380. http://dx.doi.org/10.1111/j.1365-2958.2005.04921.x.
33. Willey JM, Willems A, Kodani S, Nodwell JR. 2006. Morphogenetic surfactants and their role in the formation of aerial hyphae in Streptomyces coelicolor. Mol Microbiol 59:731-742. http://dx.doi.org/10.1111/j.1365-2958.2005.05018.x.
34. Schwartz B, Markwalder JA, Wang Y. 2001. Lipid II: total synthesis of the bacterial cell wall precursor and utilization as a substrate for glycosyltransfer and transpeptidation by penicillin binding protein (PBP) 1b of Escherichia coli. J Am Chem Soc 123:11638-11643. http://dx.doi.org/10.1021/ja0166848.
35. Lazar K, Walker S. 2002. Substrate analogues to study cell-wall biosynthesis and its inhibition. Curr Opin Chem Biol 6:786-793. http://dx.doi.org/10.1016/S1367-5931(02)00355-1.
36. Müller A, Ulm H, Reder-Christ K, Sahl HG, Schneider T. 2012. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. Microb Drug Resist 18:261-270. http://dx.doi.org/10.1089/mdr.2011.0242.
37. Kramer NE, Smid EJ, Kok J, Kruijff B, Kuipers OP, Breukink E. 2004. Resistance of Gram-positive bacteria to nisin is not determined by lipid II levels. FEMS Microbiol Lett 239:157-161. http://dx.doi.org/10.1016/j.femsle.2004.08.033.
38. Weidenmaier C, Kristian SA, Peschel A. 2003. Bacterial resistance to antimicrobial host defenses - an emerging target for novel antiinfective strategies? Curr Drug Targets 4:643-649. http://dx.doi.org/10.2174/1389450033490731.
39. Ward J. 1981. Teichoic and teichuronic acids: biosynthesis, assembly, and location. Microbiol Rev 45:211.
40. Hancock IC, Baddiley J. 1985. Biosynthesis of the bacterial envelope polymers teichoic acid and teichuronic acid, p 279-307. In Martonosi A (ed), The enzymes of biological membranes. Springer, New York, NY.
41. Fischer W. 1988. Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol 29:233-302. http://dx.doi.org/10.1016/S0065-2911(08)60349-5.
42. Perego M, Glaser P, Minutello A, Strauch MA, Leopold K, Fischer W. 1995. Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. Identification of genes and regulation. J Biol Chem 270:15598-15606.
43. Neuhaus FC, Baddiley J. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol Mol Biol Rev 67:686-723. http://dx.doi.org/10.1128/MMBR.67.4.686-723.2003.
44. Heaton MP, Neuhaus FC. 1992. Biosynthesis of D-alanyl-lipoteichoic acid: cloning, nucleotide sequence, and expression of the Lactobacillus casei gene for the D-alanine-activating enzyme. J Bacteriol 174:4707-4717.
45. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274:8405-8410. http://dx.doi.org/10.1074/jbc.274.13.8405.
46. Poyart C, Lamy MC, Boumaila C, Fiedler F, Trieu-Cuot P. 2001. Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J Bacteriol 183:6324-6334. http://dx.doi.org/10.1128/JB.183.21.6324-6334.2001.
47. McBride SM, Sonenshein AL. 2011. The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. Microbiology 157:1457-1465. http://dx.doi.org/10.1099/mic.0.045997-0.
48. Abachin E, Poyart C, Pellegrini E, Milohanic E, Fiedler F, Berche P, Trieu-Cuot P. 2002. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol 43: 1-14. http://dx.doi.org/10.1046/j.1365-2958.2002.02723.x.
49. Kovacs M, Halfmann A, Fedtke I, Heintz M, Peschel A, Vollmer W, Hakenbeck R, Bruckner R. 2006. A functional dlt operon, encoding proteins required for incorporation of D-alanine in teichoic acids in gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae. J Bacteriol 188:5797-5805. http://dx.doi.org/10.1128/JB.00336-06.
50. Khattar ZA, Rejasse A, Destoumieux-Garzón D, Escoubas J, Sanchis V, Lereclus D, Givaudan A, Kallassy M, Nielsen-Leroux C, Gaudriault S. 2009. The dlt operon of Bacillus cereus is required for resistance to cationic antimicrobial peptides and for virulence in insects. J Bacteriol 191:7063-7073. http://dx.doi.org/10.1128/JB.00892-09.
51. Kramer NE, van Hijum SA, Knol J, Kok J, Kuipers OP. 2006. Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrob Agents Chemother 50:1753-1761. http://dx.doi.org/10.1128/AAC.50.5.1753-1761.2006.
52. Grossiord BP, Luesink EJ, Vaughan EE, Arnaud A, de Vos WM. 2003. Characterization, expression, and mutation of the Lactococcus lactis galPMKTE genes, involved in galactose utilization via the Leloir pathway. J Bacteriol 185:870-878. http://dx.doi.org/10.1128/JB.185.3.870-878.2003.
53. Mantovani HC, Russell JB. 2001. Nisin resistance of Streptococcus bovis. Appl Environ Microbiol 67:808-813. http://dx.doi.org/10.1128/AEM.67.2.808-813.2001.
54. Goffin C, Ghuysen JM. 1998. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol Mol Biol Rev 62:1079-1093.
55. Terrak M, Ghosh TK, van Heijenoort J, Van Beeumen J, Lampilas M, Aszodi J, Ayala JA, Ghuysen JM, Nguyen-Disteche M. 1999. The catalytic, glycosyl transferase and acyl transferase modules of the cell wall peptidoglycan-polymerizing penicillin-binding protein 1b of Escherichia coli. Mol Microbiol 34:350-364. http://dx.doi.org/10.1046/j.1365-2958.1999.01612.x.
56. Marrec-Fairley M, Piette A, Gallet X, Brasseur R, Hara H, Fraipont C, Ghuysen JM, Nguyen-Disteche M. 2000. Differential functionalities of amphiphilic peptide segments of the cell-septation penicillin-binding protein 3 of Escherichia coli. Mol Microbiol 37:1019-1031. http://dx.doi.org/10.1046/j.1365-2958.2000.02054.x.
57. Gravesen A, Sorensen K, Aarestrup FM, Knochel S. 2001. Spontaneous nisin-resistant Listeria monocytogenes mutants with increased expression of a putative penicillin-binding protein and their sensitivity to various antibiotics. Microb Drug Resist 7:127-135. http://dx.doi.org/10.1089/10766290152045002.
58. Guinane CM, Cotter PD, Ross RP, Hill C. 2006. Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe. Antimicrob Agents Chemother 50:2824-2828. http://dx.doi.org/10.1128/AAC.00167-06.
59. Gravesen A, Kallipolitis B, Holmstrom K, Hoiby PE, Ramnath M, Knochel S. 2004. pbp2229-mediated nisin resistance mechanism in Listeria monocytogenes confers cross-protection to class IIa bacteriocins and affects virulence gene expression. Appl Environ Microbiol 70:1669-1679. http://dx.doi.org/10.1128/AEM.70.3.1669-1679.2004.
60. Cotter PD, Guinane CM, Hill C. 2002. The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins. Antimicrob Agents Chemother 46:2784-2790. http://dx.doi.org/10.1128/AAC.46.9.2784-2790.2002.
61. Xuanyuan Z, Wu Z, Li R, Jiang D, Su J, Xu H, Bai Y, Zhang X, Saris PE, Qiao M. 2010. Loss of IrpT function in Lactococcus lactis subsp. lactis N8 results in increased nisin resistance. Curr Microbiol 61:329-334. http://dx.doi.org/10.1007/s00284-010-9615-4.
62. Tsukioka Y, Yamashita Y, Nakano Y, Oho T, Koga T. 1997. Identification of a fourth gene involved in dTDP-rhamnose synthesis in Streptococcus mutans. J Bacteriol 179:4411-4414.
63. Leggett MJ, McDonnell G, Denyer SP, Setlow P, Maillard JY. 2012. Bacterial spore structures and their protective role in biocide resistance. J Appl Microbiol 113:485-498. http://dx.doi.org/10.1111/j.1365-2672.2012.05336.x.
64. Mazzotta AS, Crandall AD, Montville TJ. 1997. Nisin resistance in Clostridium botulinum spores and vegetative cells. Appl Environ Microbiol 63:2654-2659.
65. Schved F, Henis Y, Juven BJ. 1994. Response of spheroplasts and chelator-permeabilized cells of Gram-negative bacteria to the action of the bacteriocins pediocin SJ-1 and nisin. Int J Food Microbiol 21:305-314. http://dx.doi.org/10.1016/0168-1605(94)90060-4.
66. Stevens KA, Sheldon BW, Klapes NA, Klaenhammer TR. 1991. Nisin treatment for inactivation of Salmonella species and other Gram-negative bacteria. Appl Environ Microbiol 57:3613-3615.
67. Brotz H, Sahl HG. 2000. New insights into the mechanism of action of lantibiotics - diverse biological effects by binding to the same molecular target. J Antimicrob Chemother 46:1-6. http://dx.doi.org/10.1093/jac/46.1.1.
68. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F, Schreir M, Brade H. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217-225.
69. Kalchayanand N, Hanlin MB, Ray B. 1992. Sublethal injury makes Gram-negative and resistant Gram-positive bacteria sensitive to the bacteriocins, pediocin AcH and nisin. Lett Appl Microbiol 15:239-243. http://dx.doi.org/10.1111/j.1472-765X.1992.tb00773.x.
70. Boziaris IS, Adams MR. 2000. Transient sensitivity to nisin in cold-shocked Gram negatives. Lett Appl Microbiol 31:233-237. http://dx.doi.org/10.1046/j.1365-2672.2000.00804.x.
71. Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F. 2008. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem Biol 15:22-31. http://dx.doi.org/10.1016/j.chembiol.2007.11.009.
72. Field D, Begley M, O'Connor PM, Daly KM, Hugenholtz F, Cotter PD, Hill C, Ross RP. 2012. Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens. PLoS One 7:e46884. http://dx.doi.org/10.1371/journal.pone.0046884.
73. Ratledge C, Wilkinson SG. 1988. Microbial lipids. Academic Press, London, United Kingdom.
74. DiRusso CC, Nystrom T. 1998. The fats of Escherichia coli during infancy and old age: regulation by global regulators, alarmones and lipid intermediates. Mol Microbiol 27:1-8. http://dx.doi.org/10.1046/j.1365-2958.1998.00645.x.
75. Huijbregts RP, de Kroon AI, de Kruijff B. 2000. Topology and transport of membrane lipids in bacteria. Biochim Biophys Acta 1469:43-61. http://dx.doi.org/10.1016/S0304-4157(99)00014-3.
76. Matsumoto K. 2001. Dispensable nature of phosphatidylglycerol in Escherichia coli: dual roles of anionic phospholipids. Mol Microbiol 39: 1427-1433. http://dx.doi.org/10.1046/j.1365-2958.2001.02320.x.
77. de Mendoza D, Grau R, Cronan JE. 1993. Biosynthesis and function of membrane lipids, p 411-421. In Sonenshein AL, Hoch JA, Losick R (ed), Bacillus subtilis and other Gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, DC.
78. Nahaie MR, Goodfellow M, Minnikin DE, Hajek V. 1984. Polar lipid and isoprenoid quinone composition in the classification of Staphylococcus. J Gen Microbiol 130:2427-2437.
79. Fischer W, Leopold K. 1999. Polar lipids of four Listeria species containing L-lysylcardiolipin, a novel lipid structure, and other unique phospholipids. Int J Syst Bacteriol 49:653-662. http://dx.doi.org/10.1099/00207713-49-2-653.
80. Verheul A, Russell NJ, Hof RVT, Rombouts FM, Abee T. 1997. Modifications of membrane phospholipid composition in nisin-resistant Listeria monocytogenes Scott A. Appl Environ Microbiol 63: 3451-3457.
81. Demel RA, Peelen T, Siezen RJ, Kruijff B, Kuipers OP. 1996. Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity. Eur J Biochem 235:267-274. http://dx.doi.org/10.1111/j.1432-1033.1996.00267.x.
82. Crandall AD, Montville TJ. 1998. Nisin resistance in Listeria monocytogenes ATCC 700302 is a complex phenotype. Appl Environ Microbiol 64:231-237.
83. Ming X, Daeschel MA. 1995. Correlation of cellular phospholipid content with nisin resistance of Listeria monocytogenes Scott A. J Food Prot 58:416-420.
84. Mazzotta AS, Montville TJ. 1997. Nisin induces changes in membrane fatty acid composition of Listeria monocytogenes nisin-resistant strains at 10 degrees C and 30 degrees C. J Appl Microbiol 82:32-38. http://dx.doi.org/10.1111/j.1365-2672.1997.tb03294.x.
85. Ming X, Daeschel MA. 1993. Nisin resistance of foodborne bacteria and the specific resistance responses of Listeria monocytogenes Scott A. J Food Prot 11:927-1005.
86. Martinez B, Rodriguez A. 2005. Antimicrobial susceptibility of nisin resistant Listeria monocytogenes of dairy origin. FEMS Microbiol Lett 252:67-72. http://dx.doi.org/10.1016/j.femsle.2005.08.025.
87. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J Exp Med 193:1067-1076. http://dx.doi.org/10.1084/jem.193.9.1067.
88. Thedieck K, Hain T, Mohamed W, Tindall BJ, Nimtz M, Chakraborty T, Wehland J, Jansch L. 2006. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol Microbiol 62:1325-1339. http://dx.doi.org/10.1111/j.1365-2958.2006.05452.x.
89. Maloney E, Stankowska D, Zhang J, Fol M, Cheng QJ, Lun S, Bishai WR, Rajagopalan M, Chatterjee D, Madiraju MV. 2009. The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. PLoS Pathog 5:e1000534. http://dx.doi.org/10.1371/journal.ppat.1000534.
90. Staubitz P, Peschel A. 2002. MprF-mediated lysinylation of phospholipids in Bacillus subtilis - protection against bacteriocins in terrestrial habitats? Microbiology 148:3331-3332.
91. Samant S, Hsu FF, Neyfakh AA, Lee H. 2009. The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides. J Bacteriol 191:1311-1319. http://dx.doi.org/10.1128/JB.01345-08.
92. Lennarz WJ, Nesbitt JA, 3rd, Reiss J. 1966. The participation of sRNA in the enzymatic synthesis of O-L-lysyl phosphatidylglycerol in Staphylococcus aureus. Proc Natl Acad Sci U S A 55:934-941. http://dx.doi.org/10.1073/pnas.55.4.934.
93. Gould RM, Lennarz WJ. 1967. Biosynthesis of aminoacyl derivatives of phosphatidylglycerol. Biochem Biophys Res Commun 26:512-515.
94. Staubitz P, Neumann H, Schneider T, Wiedemann I, Peschel A. 2004. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett 231:67-71. http://dx.doi.org/10.1016/S0378-1097(03)00921-2.
95. Roy H. 2009. Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol. IUBMB Life 61:940-953. http://dx.doi.org/10.1002/iub.240.
96. Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A. 2009. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog 5:e1000660. http://dx.doi.org/10.1371/journal.ppat.1000660.
97. Roy H, Ibba M. 2008. RNA-dependent lipid remodeling by bacterial multiple peptide resistance factors. Proc Natl Acad Sci U S A 105:4667-4672. http://dx.doi.org/10.1073/pnas.0800006105.
98. Bao Y, Sakinc T, Laverde D, Wobser D, Benachour A, Theilacker C, Hartke A, Huebner J. 2012. Role of mprF1 and mprF2 in the pathogenicity of Enterococcus faecalis. PLoS One 7:e38458. http://dx.doi.org/10.1371/journal.pone.0038458.
99. Roy H, Ibba M. 2009. Broad range amino acid specificity of RNA-dependent lipid remodeling by multiple peptide resistance factors. J Biol Chem 284:29677-29683. http://dx.doi.org/10.1074/jbc.M109.046367.
100. Houtsmuller UM, van Deenen L. 1963. Identification of a bacterial phospholipid as an O-ornithine ester of phosphatidyl glycerol. Biochim Biophys Acta 70:211-213. http://dx.doi.org/10.1016/0006-3002(63)90743-1.
101. Slavetinsky CJ, Peschel A, Ernst CM. 2012. Alanylphos-phatidylglycerol and lysyl-phosphatidylglycerol are translocated by the same MprF flippases and have similar capacities to protect against the antibiotic daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 56:3492-3497. http://dx.doi.org/10.1128/AAC.00370-12.
102. Arendt W, Hebecker S, Jager S, Nimtz M, Moser J. 2012. Resistance phenotypes mediated by aminoacyl-phosphatidylglycerol synthases. J Bacteriol 194:1401-1416. http://dx.doi.org/10.1128/JB.06576-11.
103. Klein S, Lorenzo C, Hoffmann S, Walther JM, Storbeck S, Piekarski T, Tindall BJ, Wray V, Nimtz M, Moser J. 2009. Adaptation of Pseudomonas aeruginosa to various conditions includes tRNA-dependent formation of alanyl-phosphatidylglycerol. Mol Microbiol 71:551-565. http://dx.doi.org/10.1111/j.1365-2958.2008.06562.x.
104. Heath RJ, Rock CO. 1995. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli. J Biol Chem 270:26538-26542. http://dx.doi.org/10.1074/jbc.270.44.26538.
105. Dintner S, Staron A, Berchtold E, Petri T, Mascher T, Gebhard S. 2011. Coevolution of ABC transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes Bacteria. J Bacteriol 193:3851-3862. http://dx.doi.org/10.1128/JB.05175-11.
106. Mascher T. 2006. Intramembrane-sensing histidine kinases: a new family of cell envelope stress sensors in Firmicutes bacteria. FEMS Microbiol Lett 264:133-144. http://dx.doi.org/10.1111/j.1574-6968.2006.00444.x.
107. Falord M, Karimova G, Hiron A, Msadek T. 2012. GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus. Antimicrob Agents Chemother 56:1047-1058. http://dx.doi.org/10.1128/AAC.05054-11.
108. Hiron A, Falord M, Valle J, Debarbouille M, Msadek T. 2011. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol Microbiol 81:602-622. http://dx.doi.org/10.1111/j.1365-2958.2011.07735.x.
109. Rietkotter E, Hoyer D, Mascher T. 2008. Bacitracin sensing in Bacillus subtilis. Mol Microbiol 68:768-785. http://dx.doi.org/10.1111/j.1365-2958.2008.06194.x.
110. Staron A, Finkeisen DE, Mascher T. 2011. Peptide antibiotic sensing and detoxification modules of Bacillus subtilis. Antimicrob Agents Chemother 55:515-525. http://dx.doi.org/10.1128/AAC.00352-10.
111. Ouyang J, Tian XL, Versey J, Wishart A, Li YH. 2010. The BceABRS four-component system regulates the bacitracin-induced cell envelope stress response in Streptococcus mutans. Antimicrob Agents Chemother 54:3895-3906. http://dx.doi.org/10.1128/AAC.01802-09.
112. Revilla-Guarinos A, Gebhard S, Alcantara C, Staron A, Mascher T, Zuniga M. 2013. Characterization of a regulatory network of peptide antibiotic detoxification modules in Lactobacillus casei BL23. Appl Environ Microbiol 79:3160-3170. http://dx.doi.org/10.1128/AEM.00178-13.
113. Gebhard S, Fang C, Shaaly A, Leslie DJ, Weimar MR, Kalamorz F, Carne A, Cook GM. 2014. Identification and characterization of a bacitracin resistance network in Enterococcus faecalis. Antimicrob Agents Chemother 58:1425-1433. http://dx.doi.org/10.1128/AAC.02111-13.
114. Arthur M, Depardieu F, Molinas C, Reynolds P, Courvalin P. 1995. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 154:87-92. http://dx.doi.org/10.1016/0378-1119(94)00851-I.
115. Saier MH, Jr, Yen MR, Noto K, Tamang DG, Elkan C. 2009. The Transporter Classification Database: recent advances. Nucleic Acids Res 37:D274-D278. http://dx.doi.org/10.1093/nar/gkn862.
116. Mascher T, Margulis NG, Wang T, Ye RW, Helmann JD. 2003. Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon. Mol Microbiol 50:1591-1604. http://dx.doi.org/10.1046/j.1365-2958.2003.03786.x.
117. Ohki R, Giyanto, Tateno K, Masuyama W, Moriya S, Kobayashi K, Ogasawara N. 2003. The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis. Mol Microbiol 49:1135-1144. http://dx.doi.org/10.1046/j.1365-2958.2003.03653.x.
118. Kallenberg F, Dintner S, Schmitz R, Gebhard S. 2013. Identification of regions important for resistance and signalling within the antimicrobial peptide transporter BceAB of Bacillus subtilis. J Bacteriol 195:3287-3297. http://dx.doi.org/10.1128/JB.00419-13.
119. Kingston AW, Zhao H, Cook GM, Helmann JD. 2014. Accumulation of heptaprenyl diphosphate sensitizes Bacillus subtilis to bacitracin: implications for the mechanism of resistance mediated by the BceAB transporter. Mol Microbiol 93:37-49. http://dx.doi.org/10.1111/mmi.12637.
120. Pietiainen M, Gardemeister M, Mecklin M, Leskela S, Sarvas M, Kontinen VP. 2005. Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems. Microbiology 151: 1577-1592. http://dx.doi.org/10.1099/mic.0.27761-0.
121. Alcantara C, Revilla-Guarinos A, Zuniga M. 2011. Influence of two-component signal transduction systems of Lactobacillus casei BL23 on tolerance to stress conditions. Appl Environ Microbiol 77:1516-1519. http://dx.doi.org/10.1128/AEM.02176-10.
122. Kolar SL, Nagarajan V, Oszmiana A, Rivera FE, Miller HK, Davenport JE, Riordan JT, Potempa J, Barber DS, Koziel J, Elasri MO, Shaw LN. 2011. NsaRS is a cell-envelope-stress-sensing two-component system of Staphylococcus aureus. Microbiology 157:2206-2219. http://dx.doi.org/10.1099/mic.0.049692-0.
123. Yoshida Y, Matsuo M, Oogai Y, Kato F, Nakamura N, Sugai M, Komatsuzawa H. 2011. Bacitracin sensing and resistance in Staphylococcus aureus. FEMS Microbiol Lett 320:33-39. http://dx.doi.org/10.1111/j.1574-6968.2011.02291.x.
124. Kawada-Matsuo M, Yoshida Y, Zendo T, Nagao J, Oogai Y, Nakamura Y, Sonomoto K, Nakamura N, Komatsuzawa H. 2013. Three distinct two-component systems are involved in resistance to the class I bacteriocins, nukacin ISK-1 and nisin A, in Staphylococcus aureus. PLoS One 8:e69455. http://dx.doi.org/10.1371/journal.pone.0069455.
125. Blake KL, Randall CP, O'Neill AJ. 2011. In vitro studies indicate a high resistance potential for the lantibiotic nisin in Staphylococcus aureus and define a genetic basis for nisin resistance. Antimicrob Agents Chemother 55:2362-2368. http://dx.doi.org/10.1128/AAC.01077-10.
126. Kohler T, Weidenmaier C, Peschel A. 2009. Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin. J Bacteriol 191:4482-4484. http://dx.doi.org/10.1128/JB.00221-09.
127. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. 2007. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66:1136-1147. http://dx.doi.org/10.1111/j.1365-2958.2007.05986.x.
128. Cui L, Lian JQ, Neoh HM, Reyes E, Hiramatsu K. 2005. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother 49:3404-3413. http://dx.doi.org/10.1128/AAC.49.8.3404-3413.2005.
129. Meehl M, Herbert S, Gotz F, Cheung A. 2007. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother 51:2679-2689. http://dx.doi.org/10.1128/AAC.00209-07.
130. Kuroda M, Kuwahara-Arai K, Hiramatsu K. 2000. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem Biophys Res Commun 269:485-490. http://dx.doi.org/10.1006/bbrc.2000.2277.
131. Matsuo M, Oogai Y, Kato F, Sugai M, Komatsuzawa H. 2011. Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus. Microbiology 157:1786-1797. http://dx.doi.org/10.1099/mic.0.044727-0.
132. Falord M, Mader U, Hiron A, Debarbouille M, Msadek T. 2011. Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways. PLoS One 6:e21323. http://dx.doi.org/10.1371/journal.pone.0021323.
133. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M. 2007. Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A104:9469-9474. http://dx.doi.org/10.1073/pnas.0702159104.
134. Collins B, Curtis N, Cotter PD, Hill C, Ross RP. 2010. The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics. Antimicrob Agents Chemother 54:4416-4423. http://dx.doi.org/10.1128/AAC.00503-10.
135. Mandin P, Fsihi H, Dussurget O, Vergassola M, Milohanic E, Toledo-Arana A, Lasa I, Johansson J, Cossart P. 2005. VirR, a response regulator critical for Listeria monocytogenes virulence. Mol Microbiol 57: 1367-1380. http://dx.doi.org/10.1111/j.1365-2958.2005.04776.x.
136. Arous S, Buchrieser C, Folio P, Glaser P, Namane A, Hebraud M, Hechard Y. 2004. Global analysis of gene expression in an rpoN mutant of Listeria monocytogenes. Microbiology 150:1581-1590. http://dx.doi.org/10.1099/mic.0.26860-0.
137. Gebhard S, Mascher T. 2011. Antimicrobial peptide sensing and detoxification modules: unravelling the regulatory circuitry of Staphylococcus aureus. Mol Microbiol 81:581-587. http://dx.doi.org/10.1111/j.1365-2958.2011.07747.x.
138. Majchrzykiewicz JA, Kuipers OP, Bijlsma JJ. 2010. Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin. Antimicrob Agents Chemother 54:440-451. http://dx.doi.org/10.1128/AAC.00769-09.
139. Wolf D, Kalamorz F, Wecke T, Juszczak A, Mäder U, Homuth G, Jordan S, Kirstein J, Hoppert M, Voigt B. 2010. In-depth profiling of the LiaR response of Bacillus subtilis. J Bacteriol 192:4680-4693. http://dx.doi.org/10.1128/JB.00543-10.
140. Jordan S, Junker A, Helmann JD, Mascher T. 2006. Regulation of LiaRS-dependent gene expression in Bacillus subtilis: identification of inhibitor proteins, regulator binding sites, and target genes of a conserved cell envelope stress-sensing two-component system. J Bacteriol 188:5153-5166. http://dx.doi.org/10.1128/JB.00310-06.
141. Mascher T, Zimmer SL, Smith TA, Helmann JD. 2004. Antibioticinducible promoter regulated by the cell envelope stress-sensing two-component system LiaRS of Bacillus subtilis. Antimicrob Agents Chemother 48:2888-2896. http://dx.doi.org/10.1128/AAC.48.8.2888-2896.2004.
142. Wolf D, Dominguez-Cuevas P, Daniel RA, Mascher T. 2012. Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilis. Antimicrob Agents Chemother 56:5907-5915. http://dx.doi.org/10.1128/AAC.00770-12.
143. Fritsch F, Mauder N, Williams T, Weiser J, Oberle M, Beier D. 2011. The cell envelope stress response mediated by the LiaFSRLm three-component system of Listeria monocytogenes is controlled via the phosphatase activity of the bifunctional histidine kinase LiaSLm. Microbiology 157:373-386. http://dx.doi.org/10.1099/mic.0.044776-0.
144. Collins B, Guinane CM, Cotter PD, Hill C, Ross RP. 2012. Assessing the contributions of the LiaS histidine kinase to the innate resistance of Listeria monocytogenes to nisin, cephalosporins, and disinfectants. Appl Environ Microbiol 78:2923-2929. http://dx.doi.org/10.1128/AEM.07402-11.
145. Collins B, Joyce S, Hill C, Cotter PD, Ross RP. 2010. TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics. Antimicrob Agents Chemother 54:4658-4663. http://dx.doi.org/10.1128/AAC.00290-10.
146. Bergholz TM, Tang S, Wiedmann M, Boor KJ. 2013. Nisin resistance of Listeria monocytogenes is increased by exposure to salt stress and is mediated via LiaR. Appl Environ Microbiol 79:5682-5688. http://dx.doi.org/10.1128/AEM.01797-13.
147. Klinzing DC, Ishmael N, Dunning Hotopp JC, Tettelin H, Shields KR, Madoff LC, Puopolo KM. 2013. The two-component response regulator LiaR regulates cell wall stress responses, pili expression and virulence in group B Streptococcus. Microbiology 159:1521-1534. http://dx.doi.org/10.1099/mic.0.064444-0.
148. Suntharalingam P, Senadheera MD, Mair RW, Levesque CM, Cvitkovitch DG. 2009. The LiaFSR system regulates the cell envelope stress response in Streptococcus mutans. J Bacteriol 191:2973-2984. http://dx.doi.org/10.1128/JB.01563-08.
149. McCormick NE, Halperin SA, Song F. 2011. Regulation of D-alanylation of lipoteichoic acid in Streptococcus gordonii. Microbiology 157:2248-2256. http://dx.doi.org/10.1099/mic.0.048140-0.
150. O'Connell-Motherway M, van Sinderen D, Morel-Deville F, Fitzgerald GF, Ehrlich SD, Morel P. 2000. Six putative two-component regulatory systems isolated from Lactococcus lactis subsp. cremoris MG1363. Microbiology 146:935-947.
151. Martinez B, Zomer AL, Rodriguez A, Kok J, Kuipers OP. 2007. Cell envelope stress induced by the bacteriocin Lcn972 is sensed by the lactococcal two-component system CesSR. Mol Microbiol 64:473-486. http://dx.doi.org/10.1111/j.1365-2958.2007.05668.x.
152. Dubrac S, Boneca IG, Poupel O, Msadek T. 2007. New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J Bacteriol 189:8257-8269. http://dx.doi.org/10.1128/JB.00645-07.
153. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 49:807-821. http://dx.doi.org/10.1046/j.1365-2958.2003.03599.x.
154. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K. 1998. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 42:199-209. http://dx.doi.org/10.1093/jac/42.2.199.
155. Sass P, Jansen A, Szekat C, Sass V, Sahl HG, Bierbaum G. 2008. The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus. BMC Microbiol 8:186. http://dx.doi.org/10.1186/1471-2180-8-186.
156. Muthaiyan A, Silverman JA, Jayaswal RK, Wilkinson BJ. 2008. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob Agents Chemother 52:980-990. http://dx.doi.org/10.1128/AAC.01121-07.
157. McCallum N, Meier PS, Heusser R, Berger-Bachi B. 2011. Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus. Antimicrob Agents Chemother 55:1391-1402. http://dx.doi.org/10.1128/AAC.01213-10.
158. McAleese F, Wu SW, Sieradzki K, Dunman P, Murphy E, Projan S, Tomasz A. 2006. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. aureus-type resistance to vancomycin. J Bacteriol 188: 1120-1133. http://dx.doi.org/10.1128/JB.188.3.1120-1133.2006.
159. Berscheid A, François P, Strittmatter A, Gottschalk G, Schrenzel J, Sass P, Bierbaum G. 2014. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS. J Antimicrob Chemother 69:3190-3198. http://dx.doi.org/10.1093/jac/dku297.
160. Cotter PD, Emerson N, Gahan CG, Hill C. 1999. Identification and disruption of lisRK, a genetic locus encoding a two-component signal transduction system involved in stress tolerance and virulence in Listeria monocytogenes. J Bacteriol 181:6840-6843.
161. Kallipolitis BH, Ingmer H. 2001. Listeria monocytogenes response regulators important for stress tolerance and pathogenesis. FEMS Microbiol Lett 204:111-115. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10872.x.
162. Camejo A, Buchrieser C, Couve E, Carvalho F, Reis O, Ferreira P, Sousa S, Cossart P, Cabanes D. 2009. In vivo transcriptional profiling of Listeria monocytogenes and mutagenesis identify new virulence factors involved in infection. PLoS Pathog 5:e1000449. http://dx.doi.org/10.1371/journal.ppat.1000449.
163. Suarez JM, Edwards AN, McBride SM. 2013. The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics. J Bacteriol 195:2621-2631. http://dx.doi.org/10.1128/JB.00166-13.
164. McBride SM, Sonenshein AL. 2011. Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect Immun 79:167-176. http://dx.doi.org/10.1128/IAI.00731-10.
165. Kawada-Matsuo M, Oogai Y, Zendo T, Nagao J, Shibata Y, Yamashita Y, Ogura Y, Hayashi T, Sonomoto K, Komatsuzawa H. 2013. Involvement of the novel two-component NsrRS and LcrRS systems in distinct resistance pathways against nisin A and nukacin ISK-1 in Streptococcus mutans. Appl Environ Microbiol 79:4751-4755. http://dx.doi.org/10.1128/AEM.00780-13.
166. Saising J, Dube L, Ziebandt AK, Voravuthikunchai SP, Nega M, Gotz F. 2012. Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 56:5804-5810. http://dx.doi.org/10.1128/AAC.01296-12.
167. Dobson A, O'Connor PM, Cotter PD, Ross RP, Hill C. 2011. Impact of the broad-spectrum antimicrobial peptide, lacticin 3147, on Streptococcus mutans growing in a biofilm and in human saliva. J Appl Microbiol 111:1515-1523. http://dx.doi.org/10.1111/j.1365-2672.2011.05153.x.
168. Nguyen T, Zhang Z, Huang IH, Wu C, Merritt J, Shi W, Qi F. 2009. Genes involved in the repression of mutacin I production in Streptococcus mutans. Microbiology 155:551-556. http://dx.doi.org/10.1099/mic.0.021303-0.
169. Sudagidan M, Yemenicioglu A. 2012. Effects of nisin and lysozyme on growth inhibition and biofilm formation capacity of Staphylococcus aureus strains isolated from raw milk and cheese samples. J Food Prot 75: 1627-1633. http://dx.doi.org/10.4315/0362-028X.JFP-12-001.
170. Okuda KI, Zendo T, Sugimoto S, Iwase T, Tajima A, Yamada S, Sonomoto K, Mizunoe Y. 2013. Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob Agents Chemother 57:5572-5579. http://dx.doi.org/10.1128/AAC.00888-13.
171. Asaduzzaman SM, Nagao J, Iida H, Zendo T, Nakayama J, Sonomoto K. 2009. Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrob Agents Chemother 53:3595-3598. http://dx.doi.org/10.1128/AAC.01623-08.
172. Yoneyama F, Imura Y, Ohno K, Zendo T, Nakayama J, Matsuzaki K, Sonomoto K. 2009. Peptide-lipid huge toroidal pore, a new anti-microbial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Antimicrob Agents Chemother 53:3211-3217. http://dx.doi.org/10.1128/AAC.00209-09.
173. Yamakami K, Tsumori H, Sakurai Y, Shimizu Y, Nagatoshi K, Sonomoto K. 2013. Sustainable inhibition efficacy of liposome-encapsulated nisin oninsoluble glucan-biofilm synthesis by Streptococcus mutans. Pharm Biol 51:267-270. http://dx.doi.org/10.3109/13880209.2012.717227.
174. Tong Z, Zhou L, Jiang W, Kuang R, Li J, Tao R, Ni L. 2011. An in vitro synergetic evaluation of the use of nisin and sodium fluoride or chlorhexidine against Streptococcus mutans. Peptides 32:2021-2026. http://dx.doi.org/10.1016/j.peptides.2011.09.002.
175. Dosler S, Mataraci E. 2013. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms. Peptides 49:53-58. http://dx.doi.org/10.1016/j.peptides.2013.08.008.
176. Qi X, Poernomo G, Wang K, Chen Y, Chan-Park MB, Xu R, Chang MW. 2011. Covalent immobilization of nisin on multi-walled carbon nanotubes: superior antimicrobial and anti-biofilm properties. Nanoscale 3:1874-1880. http://dx.doi.org/10.1039/c1nr10024f.
177. Hequet A, Humblot V, Berjeaud JM, Pradier CM. 2011. Optimized grafting of antimicrobial peptides on stainless steel surface and biofilm resistance tests. Colloids Surf B Biointerfaces 84:301-309. http://dx.doi.org/10.1016/j.colsurfb.2011.01.012.
178. Nostro A, Scaffaro R, Ginestra G, D'Arrigo M, Botta L, Marino A, Bisignano G. 2010. Control of biofilm formation by poly-ethylene-covinyl acetate films incorporating nisin. Appl Microbiol Biotechnol 87: 729-737. http://dx.doi.org/10.1007/s00253-010-2598-z.
179. Conlon B, Nakayasu E, Fleck L, LaFleur M, Isabella V, Coleman K, Leonard S, Smith R, Adkins J, Lewis K. 2013. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503:365-370. http://dx.doi.org/10.1038/nature12790.
180. Froseth BR, McKay LL. 1991. Molecular characterization of the nisin resistance region of Lactococcus lactis subsp. lactis biovar diacetylactis DRC3. Appl Environ Microbiol 57:804-811.
181. Liu CQ, Harvey ML, Dunn NW. 1997. Cloning of a gene encoding nisin resistance from Lactococcus lactis subsp. lactis M189 which is transcribed from an extended 210 promoter. J Gen Appl Microbiol 43:67-73. http://dx.doi.org/10.2323/jgam.43.67.
182. Yun XX, Hu J, Chen Q. 2006. Screening, isolation and identification of nisin resistance determinant gene in strains of Lactococcus lactis. Nan Fang Yi Ke Da Xue Xue Bao 26:839-842.
183. Sun Z, Zhong J, Liang X, Liu J, Chen X, Huan L. 2009. Novel mechanism for nisin resistance via proteolytic degradation of nisin by the nisin resistance protein NSR. Antimicrob Agents Chemother 53:1964-1973. http://dx.doi.org/10.1128/AAC.01382-08.
184. Chatterjee C, Paul M, Xie L, van der Donk WA. 2005. Biosynthesis and mode of action of lantibiotics. Chem Rev 105:633-684. http://dx.doi.org/10.1021/cr030105v.
185. O'Driscoll J, Glynn F, Fitzgerald GF, van Sinderen D. 2006. Sequence analysis of the lactococcal plasmid pNP40: a mobile replicon for coping with environmental hazards. J Bacteriol 188:6629-6639. http://dx.doi.org/10.1128/JB.00672-06.
186. Keiler KC, Silber KR, Downard KM, Papayannopoulos IA, Biemann K, Sauer RT. 1995. C-terminal specific protein degradation: activity and substrate specificity of the Tsp protease. Protein Sci 4:1507-1515. http://dx.doi.org/10.1002/pro.5560040808.
187. Beebe KD, Shin J, Peng J, Chaudhury C, Khera J, Pei D. 2000. Substrate recognition through a PDZ domain in tail-specific protease. Biochemistry 39:3149-3155. http://dx.doi.org/10.1021/bi992709s.
188. Spiers A, Lamb HK, Cocklin S, Wheeler KA, Budworth J, Dodds AL, Pallen MJ, Maskell DJ, Charles IG, Hawkins AR. 2002. PDZ domains facilitate binding of high temperature requirement protease A (HtrA) and tail-specific protease (Tsp) to heterologous substrates through recognition of the small stable RNA A (ssrA)-encoded peptide. J Biol Chem 277:39443-39449. http://dx.doi.org/10.1074/jbc.M202790200.
189. Keiler KC, Sauer RT. 1996. Sequence determinants of C-terminal substrate recognition by the Tsp protease. J Biol Chem 271:2589-2593. http://dx.doi.org/10.1074/jbc.271.5.2589.
190. Khosa S, Alkhatib Z, Smits SH. 2013. NSR from Streptococcus agalactiae confers resistance against nisin and is encoded by a conserved nsr operon. Biol Chem 394:1543-1549. http://dx.doi.org/10.1515/hsz-2013-0167.
191. Jarvis B. 1967. Resistance to nisin and production of nisin-inactivating enzymes by several Bacillus species. J Gen Microbiol 47:33-48. http://dx.doi.org/10.1099/00221287-47-1-33.
192. Jarvis B. 1970. Enzymic reduction of the C-terminal dehydroalanyllysine sequence in nisin. Biochem J 119:56P.
193. Kooy J. 1952. Strains of Lactobacillus plantarum which inhibit the activity of the antibiotics produced by Streptococcus lactis. Neth Milk Dairy J 6:323.
194. Alifax R, Chevalier R. 1962. Study of the nisinase produced by Streptococcus thermophilus. J Dairy Res 29:233-240.
195. Rayman K, Malik N, Hurst A. 1983. Failure of nisin to inhibit out-growth of Clostridium botulinum in a model cured meat system. Appl Environ Microbiol 46:1450-1452.
196. Carlson S, Bauer H. 1957. A study of problems associated with resistance to nisin. Arch Hyg Bakteriol 141:445-460.
197. Cotter PD, O'Reilly K, Hill C. 2001. Role of the glutamate decarboxylase acid resistance system in the survival of Listeria monocytogenes LO28 in low pH foods. J Food Prot 64:1362-1368.
198. Cotter PD, Ryan S, Gahan CG, Hill C. 2005. Presence of GadD1 glutamate decarboxylase in selected Listeria monocytogenes strains is associated with an ability to grow at low pH. Appl Environ Microbiol 71:2832-2839. http://dx.doi.org/10.1128/AEM.71.6.2832-2839.2005.
199. Cotter PD, Gahan CG, Hill C. 2001. A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid. Mol Microbiol 40:465-475. http://dx.doi.org/10.1046/j.1365-2958.2001.02398.x.
200. Begley M, Cotter PD, Hill C, Ross RP. 2010. Glutamate decarboxylase-mediated nisin resistance in Listeria monocytogenes. Appl Environ Microbiol 76:6541-6546. http://dx.doi.org/10.1128/AEM.00203-10.
201. Poolman B, Driessen A, Konings W. 1987. Regulation of arginine-ornithine exchange and the arginine deiminase pathway in Streptococcus lactis. J Bacteriol 169:5597-5604.
202. Kristich CJ, Wells CL, Dunny GM. 2007. A eukaryotic-type Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial resistance and intestinal persistence. Proc Natl Acad Sci U S A 104:3508-3513. http://dx.doi.org/10.1073/pnas.0608742104.
203. Hall CL, Tschannen M, Worthey EA, Kristich CJ. 2013. IreB, a Ser/Thr kinase substrate, influences antimicrobial resistance in Enterococcus faecalis. Antimicrob Agents Chemother 57:6179-6186. http://dx.doi.org/10.1128/AAC.01472-13.
204. Boylan SA, Redfield AR, Brody MS, Price CW. 1993. Stress-induced activation of the sigma B transcription factor of Bacillus subtilis. J Bacteriol 175:7931-7937.
205. Begley M, Hill C, Ross RP. 2006. Tolerance of Listeria monocytogenes to cell envelope-acting antimicrobial agents is dependent on SigB. Appl Environ Microbiol 72:2231-2234. http://dx.doi.org/10.1128/AEM.72.3.2231-2234.2006.
206. Stack HM, Sleator RD, Bowers M, Hill C, Gahan CG. 2005. Role for HtrA in stress induction and virulence potential in Listeria monocytogenes. Appl Environ Microbiol 71:4241-4247. http://dx.doi.org/10.1128/AEM.71.8.4241-4247.2005.
207. Mata MT, Baquero F, Perez-Diaz JC. 2000. A multidrug efflux transporter in Listeria monocytogenes. FEMS Microbiol Lett 187:185-188. http://dx.doi.org/10.1111/j.1574-6968.2000.tb09158.x.
208. Palmer ME, Wiedmann M, Boor KJ. 2009. Sigma(B) and sigma(L) contribute to Listeria monocytogenes 10403S response to the antimicrobial peptides SdpC and nisin. Foodborne Pathog Dis 6:1057-1065. http://dx.doi.org/10.1089/fpd.2009.0292.
209. Butcher BG, Helmann JD. 2006. Identification of Bacillus subtilis sigma-dependent genes that provide intrinsic resistance to antimicrobial compounds produced by bacilli. Mol Microbiol 60:765-782. http://dx.doi.org/10.1111/j.1365-2958.2006.05131.x.
210. Cao M, Helmann JD. 2004. The Bacillus subtilis extracytoplasmic-function sigmaX factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides. J Bacteriol 186:1136-1146. http://dx.doi.org/10.1128/JB.186.4.1136-1146.2004.
211. Cao M, Helmann JD. 2002. Regulation of the Bacillus subtilis bcrC bacitracin resistance gene by two extracytoplasmic function sigma factors. J Bacteriol 184:6123-6129. http://dx.doi.org/10.1128/JB.184.22.6123-6129.2002.
212. Bernard R, El Ghachi M, Mengin-Lecreulx D, Chippaux M, Denizot F. 2005. BcrC from Bacillus subtilis acts as an undecaprenyl pyrophosphate phosphatase in bacitracin resistance. J Biol Chem 280:28852-28857. http://dx.doi.org/10.1074/jbc.M413750200.
213. Kingston AW, Liao X, Helmann JD. 2013. Contributions of the σW, σM and σX regulons to the lantibiotic resistome of Bacillus subtilis. Mol Microbiol 90:502-518. http://dx.doi.org/10.1111/mmi.12380.
214. Lee YH, Kingston AW, Helmann JD. 2012. Glutamate dehydrogenase affects resistance to cell wall antibiotics in Bacillus subtilis. J Bacteriol 194:993-1001. http://dx.doi.org/10.1128/JB.06547-11.
215. Kingston AW, Subramanian C, Rock CO, Helmann JD. 2011. A sigma W-dependent stress response in Bacillus subtilis that reduces membrane fluidity. Mol Microbiol 81:69-79. http://dx.doi.org/10.1111/j.1365-2958.2011.07679.x.
216. Draper LA, Ross RP, Hill C, Cotter PD. 2008. Lantibiotic immunity. Curr Protein Pept Sci 9:39-49. http://dx.doi.org/10.2174/138920308783565750.
217. Draper LA, Grainger K, Deegan LH, Cotter PD, Hill C, Ross RP. 2009. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol Microbiol 71:1043-1054. http://dx.doi.org/10.1111/j.1365-2958.2008.06590.x.
218. Draper LA, Tagg JR, Hill C, Cotter PD, Ross RP. 2012. The spiFEG locus in Streptococcus infantarius subsp. infantarius BAA-102 confers protection against nisin U. Antimicrob Agents Chemother 56:573-578. http://dx.doi.org/10.1128/AAC.05778-11.